Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans
Philipp C. Rittershaus, … , Chiara Luberto, Maurizio Del Poeta
Philipp C. Rittershaus, … , Chiara Luberto, Maurizio Del Poeta
Published June 1, 2006
Citation Information: J Clin Invest. 2006;116(6):1651-1659. https://doi.org/10.1172/JCI27890.
View: Text | PDF | Corrigendum
Research Article Microbiology Article has an altmetric score of 10

Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans

  • Text
  • PDF
Abstract

The pathogenic fungus Cryptococcus neoformans infects humans upon inhalation and causes the most common fungal meningoencephalitis in immunocompromised subjects worldwide. In the host, C. neoformans is found both intracellularly and extracellularly, but how these two components contribute to the development of the disease is largely unknown. Here we show that the glycosphingolipid glucosylceramide (GlcCer), which is present in C. neoformans, was essential for fungal growth in host extracellular environments, such as in alveolar spaces and in the bloodstream, which are characterized by a neutral/alkaline pH, but not in the host intracellular environment, such as in the phagolysosome of macrophages, which is characteristically acidic. Indeed, a C. neoformans mutant strain lacking GlcCer did not grow in vitro at a neutral/alkaline pH, yet it had no growth defect at an acidic pH. The mechanism by which GlcCer regulates alkali tolerance was by allowing the transition of C. neoformans through the cell cycle. This study establishes C. neoformans GlcCer as a key virulence factor of cryptococcal pathogenicity, with important implications for future development of new antifungal strategies.

Authors

Philipp C. Rittershaus, Talar B. Kechichian, Jeremy C. Allegood, Alfred H. Merrill, Mirko Hennig, Chiara Luberto, Maurizio Del Poeta

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 Total
Citations: 4 7 5 3 15 14 6 9 5 12 12 8 4 4 15 7 5 7 4 2 148
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2021 (15)

Title and authors Publication Year
Functions of Sphingolipids in Pathogenesis During Host–Pathogen Interactions
J Wang, YL Chen, YK Li, DK Chen, JF He, N Yao
Frontiers in microbiology 2021
Treatment strategies for cryptococcal infection: challenges, advances and future outlook
KR Iyer, NM Revie, C Fu, N Robbins, LE Cowen
Nature Reviews Microbiology 2021
Vaccine-Induced Immunological Memory in Invasive Fungal Infections – A Dream so Close yet so Far
PS Biswas
Frontiers in immunology 2021
The granuloma in cryptococcal disease
LC Ristow, JM Davis, A Chowdhary
PLoS pathogens 2021
P-Type ATPase Apt1 of the Fungal Pathogen Cryptococcus neoformans Is a Lipid Flippase of Broad Substrate Specificity
LD Stanchev, J Rizzo, R Peschel, LA Pazurek, L Bredegaard, S Veit, S Laerbusch, ML Rodrigues, RL López-Marqués, TG Pomorski
Journal of Fungi 2021
Omics Approaches for Understanding Biogenesis, Composition and Functions of Fungal Extracellular Vesicles
D Zamith-Miranda, RP da Silva, SP Couvillion, EL Bredeweg, MC Burnet, C Coelho, E Camacho, L Nimrichter, R Puccia, IC Almeida, A Casadevall, ML Rodrigues, LR Alves, JD Nosanchuk, ES Nakayasu
Frontiers in Genetics 2021
Miltefosine Against Scedosporium and Lomentospora Species: Antifungal Activity and Its Effects on Fungal Cells
R Rollin-Pinheiro, Y de Castro Almeida, VP Rochetti, MI da Silva Xisto, LP Borba-Santos, S Rozental, E Barreto-Bergter
Frontiers in Cellular and Infection Microbiology 2021
Sphingolipid Inhibitors as an Alternative to Treat Candidiasis Caused by Fluconazole-Resistant Strains
R Rollin-Pinheiro, B Bayona-Pacheco, LT Domingos, JA da Rocha Curvelo, GM de Castro, E Barreto-Bergter, A Ferreira-Pereira
Pathogens 2021
Comparative Molecular and Immunoregulatory Analysis of Extracellular Vesicles from Candida albicans and Candida auris
D Zamith-Miranda, HM Heyman, SP Couvillion, RJ Cordero, ML Rodrigues, L Nimrichter, A Casadevall, RF Amatuzzi, LR Alves, ES Nakayasu, JD Nosanchuk, F Schmidt
mSystems 2021
Mass Spectrometry-Based Lipidomics: Methods and Protocols
FF Hsu
2021
Lipid Secretion by Parasitic Cells of Coccidioides Contributes to Disseminated Disease
CA Peláez-Jaramillo, MD Jiménez-Alzate, P Araque-Marin, CY Hung, N Castro-Lopez, GT Cole
Frontiers in Cellular and Infection Microbiology 2021
Differences in the Fatty Acid Profile, Morphology, and Tetraacetylphytosphingosine-Forming Capability Between Wild-Type and Mutant Wickerhamomyces ciferrii
JY Choi, HJ Hwang, WY Cho, J Choi, PC Lee
Frontiers in Bioengineering and Biotechnology 2021
Glycosphingolipids in Filamentous Fungi: Biological Roles and Potential Applications in Cosmetics and Health Foods
C Jiang, J Ge, B He, B Zeng
Frontiers in microbiology 2021
A Histoplasma capsulatum Lipid Metabolic Map Identifies Antifungal Targets
D Zamith-Miranda, HM Heyman, MC Burnet, SP Couvillion, X Zheng, N Munoz, WC Nelson, JE Kyle, EM Zink, KK Weitz, KJ Bloodsworth, G Clair, JD Zucker, JR Teuton, SH Payne, YM Kim, MR Gil, ES Baker, EL Bredeweg, JD Nosanchuk, ES Nakayasu, JW Kronstad
mBio 2021
Advances in Antifungal Drug Development: An Up-To-Date Mini Review
Bouz G, Doležal M
Pharmaceuticals 2021

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 5 patents
Highlighted by 1 platforms
115 readers on Mendeley
See more details